KIF18A Inhibitor
Showing 1 - 25 of >10,000
High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)
Not yet recruiting
- High Grade Serous Adenocarcinoma of Ovary
- +3 more
- (no location specified)
Oct 13, 2023
Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit Trial in Stanford, Portland ([18F]F-AraG)
Not yet recruiting
- Solid Tumor
- Fluorine F 18 Ara-G
-
Palo Alto, CaliforniaStanford University
Feb 1, 2022
Alzheimer Trial in New York (MW150, Placebo)
Not yet recruiting
- Alzheimer Disease
- MW150
- Placebo
-
New York, New YorkColumbia University Irving Medical Center
Mar 13, 2022
Renal Allograft Recipients Trial in Worldwide (Belatacept, Tacrolimus, Cyclosporine A)
Recruiting
- Renal Allograft Recipients
- Belatacept
- +5 more
-
Birmingham, Alabama
- +14 more
Oct 24, 2022
Grade 1 Glioma, Mixed Glio-neuronal Tumors, Pleomorphic Xanthoastrocytoma Trial in Strasbourg (Trametinib, Vinblastine)
Recruiting
- Grade 1 Glioma
- +2 more
-
Strasbourg, FranceCHU Strasbourg - France
Jul 7, 2022
Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- PF-07220060
- +3 more
- (no location specified)
Oct 24, 2023
Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI
Recruiting
- Advanced Alveolar Soft Part Sarcoma
- +3 more
- Atezolizumab
- +5 more
-
Bethesda, Maryland
- +1 more
Jan 28, 2023
Breast Cancer Trial in Saint Louis (Diagnostic Imaging ( 6a-[18F]fluoro-17ß-estradiol (FES)))
Withdrawn
- Breast Cancer
- Diagnostic Imaging ( 6α-[18F]fluoro-17β-estradiol (FES))
-
Saint Louis, MissouriMallinckrodt Institute of Radiology
Oct 21, 2021
Healthy Subject, Intracranial Tumor, Glioblastoma Trial in Palo Alto (Fluorine F 18 DASA-23, Positron Emission Tomography)
Recruiting
- Healthy Subject
- +2 more
- Fluorine F 18 DASA-23
- Positron Emission Tomography
-
Palo Alto, CaliforniaStanford University, School of Medicine
Sep 2, 2021
Chronic Kidney Disease, Proteinuria, Children Trial in Multiple Locations (Finerenone (Kerendia, BAY94-8862))
Not yet recruiting
- Chronic Kidney Disease
- +2 more
- Finerenone (Kerendia, BAY94-8862)
-
Multiple Locations, Australia
- +22 more
Aug 10, 2022
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +24 more
- 18F-Fluoromisonidazole
- +4 more
-
La Jolla, California
- +15 more
Jan 3, 2023
Cervical Cancer Trial (BAVC-C+Durvalumab)
Not yet recruiting
- Cervical Cancer
- BAVC-C+Durvalumab
- (no location specified)
Mar 14, 2021
Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)
Not yet recruiting
- Diabetes Mellitus
- +2 more
- SGLT2 inhibitor
- Glimepiride
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Aug 1, 2023
Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial
Not yet recruiting
- Waldenstrom Macroglobulinemia
- +2 more
- (no location specified)
Jul 18, 2023
Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)
Active, not recruiting
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Ravulizumab
-
Aurora, Colorado
- +19 more
Nov 16, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Healthy Adults Trial in Dallas (Treatment A, Treatment B)
Not yet recruiting
- Healthy Adults
- Treatment A
- Treatment B
-
Dallas, TexasLabcorp Clinical Research Unit Inc
May 11, 2023
Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)
Not yet recruiting
- Waldenstrom Macroglobulinemia
- B-Cell Lymphoproliferative Disorder
- Pirtobrutinib
- +2 more
-
Boston, Massachusetts
- +2 more
Feb 18, 2023
Quality of Life and Physical Fitness After Immune Checkpoint
Completed
- Melanoma
- Non Small Cell Lung Cancer
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jan 3, 2023